Illumina Launches Research Test Codeveloped with Merck to Unlock Deeper Insights into the Tumor Genome

Jun 22, 2022 New assay brings  validated HRD technology from Myriad Genetics to the Illumina TruSight™ Oncology 500, a single, comprehensive pan-cancer test to identify key variants critical for cancer development and progression SAN DIEGO, June 22, 2022 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the launch of a research... Read more

Bio-Techne to acquire single-cell sorting platform provider Namocel

JUNE 22, 2022 MINNEAPOLIS and MOUNTAIN VIEW, Mo., June 22, 2022 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced it has reached an agreement to acquire Namocell, Inc. Bio-Techne anticipates the acquisition to close in the first quarter of its... Read more

Gilson Expands its MyPIPETMAN Offering with New Technical and Customizable Features

Middleton, WI– June 22, 2022 – Gilson is pleased to announce the global launch of a novel customizable, modular pipette. MyPIPETMAN® is Gilson’s most comfortable and ergonomic pipette, offering technical and personalization options to adapt to the researcher’s laboratory needs.  The newest MyPIPETMAN mechanical pipettes are available through two main options: MyPIPETMAN Select and MyPIPETMAN Enterprise. As... Read more

Danaher Schedules Second Quarter 2022 Earnings Conference Call

WASHINGTON, June 21, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2022 on Thursday, July 21, 2022 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of... Read more

Ellutia introduces fully automated total nitrosamine testing for pharmaceuticals at Analytica 2022

Ely, Cambridgeshire, 21st June, 2022: The Ellutia 800 Series Thermal EnergyAnalyser (TEA) has become the industry standard for nitrosamine detection thanks toits selectivity and sensitivity for nitroso compounds. For testing of pharmaceuticaldrugs, the 800 Series TEA can be interfaced to a chemical stripping system thatallows for rapid testing of apparent total nitrosamine content (ATNC). This... Read more